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Oligonucleotide chips targeting the bacterial internal transcribed spacer region (ITS) of the 16S–23S rRNA
gene, which contains genus- and species-specific regions, were developed and evaluated. Forty-three sequences
were designed consisting of 1 universal, 3 Gram stain-specific, 9 genus-specific, and 30 species-specific probes.
The specificity of the probes was confirmed using bacterial type strains including 54 of 52 species belonging to
18 genera. The performance of the probes was evaluated using 825 consecutive samples that were positive by
blood culture in broth medium. Among the 825 clinical specimens, 708 (85.8%) were identified correctly by the
oligonucleotide chip. Most (536 isolates, or 75.7%) were identified as staphylococci, Escherichia coli, or
Klebsiella pneumoniae. Thirty-seven isolates (4.5%) did not bind to the corresponding specific probes. Most of
these also were staphylococci, E. coli, or K. pneumoniae and accounted for 6.3% of total number of the species.
Sixty-two specimens (7.5%) did not bind the genus- or species-specific probes because of lack of corresponding
specific probes. Among them, Acinetobacter baumannii was the single most frequent isolate (26/62). The
oligonucleotide chip was highly specific and sensitive in detecting the causative agents of bacteremia directly
from positive blood cultures.
Sepsis (bacteremia) is a serious medical condition caused by
microbial pathogens in blood, with a mortality rate as high as
50% (14). Identification of microorganisms in the blood thus
usually is indicative of a serious invasive infection necessitating
urgent antimicrobial therapy. Sepsis most often is caused by
bacteria, with fungal, parasitic, or viral infections being uncom-
mon (5). Various pathogens have different antimicrobial sus-
ceptibilities, and successful treatment is dependent on prompt
administration of the correct drug (19). Therefore, the most
important early intervention in sepsis is quick diagnosis. How-
ever, the identification of pure colonies on agar plates after
broth culture of blood takes 1 day or more. Clearly, a rapid and
accurate method for identification of pathogens is necessary.
Technical improvement in molecular techniques such as
PCR, sequencing, and oligonucleotide chip assay has increased
the sensitivity, specificity, and speed of assays (2). Oligonucle-
otide chips have recently become a powerful tool for microbial
genotyping and identification of drug resistance associated
with mutations and single-nucleotide polymorphisms (12). This
method allows thousands of specific DNA sequences to be
detected simultaneously (13). In most bacteria, the internal
transcribed spacer region (ITS) of the 16S–23S rRNA gene
contains genus- and species-specific regions and therefore is
useful as the target for species identification (7, 12). In this
study, we aimed to detect and identify important bacterial
pathogens associated with sepsis directly from blood culture by
using an ITS-targeted oligonucleotide chip.
MATERIALS AND METHODS
Design of universal and specific probes and alignment of probes in the oli-
gonucleotide chip. Forty-three sequences were designed consisting of 1 universal,
3 Gram stain-specific, 9 genus-specific, and 30 species-specific probes (Table 1).
Genus and species were selected empirically on the basis of isolation frequency
in clinical laboratories. The universal probe (Uni-459), which was designed from
the sequences of highly conserved regions of the 23S rRNA gene, was used as an
internal control to confirm the presence of genomic DNA and the adequacy of
PCR. All the other probes were designed from the ITS region between the 16S
and 23S rRNA genes using sequences obtained from the GenBank database.
Multiple alignment analysis using CLUSTALW was applied to the probe design.
The uniqueness of the sequence of each probe was analyzed with a BLAST
search. The probes were designed to satisfy the following criteria: the oligonu-
cleotides were between 18 and 27 nucleotides long, and the position of the
potential mismatch in similar sequences was close to the center of the probe. The
5 end of each probe was modified by adding poly(T) sequence and an amino link
group to enable covalent immobilizing on the aldehyde-coated glass surface.
Figure 1 illustrates the probe array on the oligonucleotide chip. Each of the
probes was spotted in triplicate.
QC probes for the oligonucleotide chip. Quality control (QC) probes were
used to confirm the uniformity of the spots. The 6-carboxytetramethylrhodamine
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(TAMRA)-labeled QC probe [15-mer poly(T)] was modified by an amino link
group at the 5 end. We spotted mixtures of each specific probe and QC probe.
All probes were stored in 50-l volumes at 100 pM/l concentrations at 20°C
for less than 6 months before use. Before hybridization, proper spotting was
confirmed by scanning at 532 nm.
Oligonucleotide chip fabrication. For printing, the probes were dispensed into
a 384-well microplate. Each well of the plate contained a mixture of a specific
probe and a QC probe (9:1 ratio) in 3 SSC (1 SSC is 0.15 M NaCl plus 0.015
M sodium citrate, pH 7.0). The oligonucleotide probes were spotted on silylated
glass slides (CEL Associates, Houston, TX) using a PixSys nQUAD 4500 Mi-
croarrayer (Cartesian Technologies, Inc., Irvine, CA). The spotted slides were
left for at least 5 h at 50°C to fix the probes to the surface. Slides were then
washed once with 0.2% SDS and distilled H2O (dH2O) for 1 min each. To reduce
Schiff base formation between the amino groups of the oligonucleotide probes
and the aldehyde groups of the glass slide, the slides were treated for 5 min with
a freshly prepared 0.25% NaBH4 solution (1.0 g of NaBH4, 300 ml of phosphate-
buffered saline [PBS], and 100 ml of absolute ethanol). Slides were washed once
in dH2O at 95°C for 2 min and once with 0.2% SDS and dH2O for 1 min each
and dried.
Type strains of bacteria and blood culture isolates. The bacterial strains listed
in Table 2 were used to hybridize the oligonucleotide chip, which included 54
strains of 52 species belonging to 18 genera. The type strains were obtained from
the American Type Culture Collection (ATCC) or the Korean Collection for
Type Cultures (KCTC). All the type strains were used for evaluating the speci-
ficity of the probe binding. Additionally, 825 consecutive samples that were
positive by blood culture broth medium assay were included, resulting in 825
bacterial species; these were collected from Pusan National University Hospital,
Kosin University Gospel Hospital, Inje University Busan Paik Hospital, Ulsan
University Hospital, and Gyeongsang National University Hospital (Table 3) by
the method described below. Blood culture assays were performed according to
each hospital’s own protocol using the BacT/Alert 3D system (Organon Teknika,
Durham, NC) or the BACTEC 9240 blood culture system (Becton Dickinson
Diagnostic Instrument Systems, Sparks, MD). When positive signals appeared, 1
ml of broth medium was drawn from the culture for the oligonucleotide chip
TABLE 1. Probes included on the chip
Target bacteria Probe name Probe sequence (5 to 3) Accession no. (GenBank)or source




Enterococcus spp. Enc GAGTTTTTTAATAAGTTCAATTG
E. faecalis Enc_fs GCTTATTTATTGATTAACC AY351321
E. faecium Enc_fm AGACTACACAATTTGTTTTT AY351317
E. avium Enc_av GGATACAGAAACAATTTTAA AY116901
Listeria spp. Lis CACAAGTAACCGAGAATCATCTG
L. monocytogenes Lis_mo CATAGATAATTTATTATTTATGAC AF514302
L. ivanovii Lis_iv CTGTATAACCTATTTAAGGG U57913
L. grayi Lis_gr GAAACTTTCCGCTTTGGAAG U57918
L. welshimeri Lis_we AGAAAACAAAATATTATTTCC U57917
Staphylococcus spp. Sta AGATTTTACCAAGCAAAACCG
S. aureus Sta_au AAACGCGTTATTAATCTTGTGA U11787
S. epidermidis Sta_ep TTGAATTCVTAAATAATCGC U90018
S. saprophyticus Sta_sa CTTACGAAGATGCAGGAAT EU430992
Streptococcus spp. Str CATTGAAAATTGAATAWCKA
S. agalactiae Str_ag AGGAAACCTGCCATTTGCGTC AF489592
S. pneumoniae Str_pn ATCACCAAGTAATGCACATTG AY347556
S. pyogenes Str_py ACACGTTTATCGTCTTATTTAG AY347560
S. bovis Str_bo GTTTAAGGTCAACAGAACCAA AY347547
Gram-negative bacteria
Nonspecific GN_01 CTCAGTTGGTTAGAGCGCSMCM
Bacteroides spp. Bac GTAGAGGTCGGCAGTTCAAC
B. fragilis Bac_fr GAAAAGGAGATGAATCTGGC AF172709
B. thetaiotaomicron Bac_th GGTTAATACCTGATACTT AF172710
B. ovatus Bac_ov CCAGTATGAGAATAAAACGTT AF176691
Escherichia coli Esc_co AAAAAAGAAGCGTWCTTTGMAGTGCTC AY684796
Enterobacter/Klebsiella spp. Kle/Enb TAATGTGTGTTCGAGTCTCT
E. cloacae Enb_cl CGAAGGGGACGTACAGTCTCA AY116915
E. aerogenes Enb_ae AAGTAGAGAAGCAAGGGGTC AF047426
E. agglomerans Enb_ag GATACCTTCCCGCGCAGTGTCC AF041584
K. pneumoniae Kle_pn GACGCGTGCCGATGTATC AF047425
K. oxytoca Kle_ox GCTGCGAAGTCGCGACACCT AY116899
Haemophilus spp. Hae CGAATCCCCGTGGGGACGCCA
H. influenzae Hae_in GAGAGAAAGTCTGAGTAGGCA Our laboratory
H. ducreyi Hae_du AAGTAGAAAGTCTGAGTAATC Our laboratory
Pseudomonas spp. Pse ACAGTATAACCAGATTGCTT
P. aeruginosa Pse_ae CCATCTAAAACAATCGTCG AY684792
P. stutzeri Pse_st CACGTTATAGACAGTAACC AJ635307
Serratia spp. Ser CCTCCTTACCTAASGATATT
S. marcescens Ser_ma GCCACTCGAACTAATATCTT Our laboratory
S. grimesii Ser_gr GATATTGATTGCGTGAAGTGC Our laboratory
S. entomophila Ser_en CACTTCACTCGAATCAATATC Our laboratory
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assay in addition to routine identification and susceptibility testing. Identification
of bacteria was performed by biochemical reactions, the Vitek 2 System (bio-
Me´rieux, Durham, NC), or both. Analysis of oligonucleotide chips was per-
formed by persons blinded to the identification results of the blood culture.
DNA extraction and PCR amplification. DNA was extracted using an In-
staGene Matrix Kit (Bio-Rad Laboratories, Richmond, CA) according to the
manufacturer’s protocol. The DNA of reference strains was extracted from
colonies on plated medium, and DNA of clinical isolates was from 1 ml of
cultivated broth. For PCR, the universal primers 5-biotin-GCCTTGTACAC
WCCGCCC-3 (forward primer) within the bacterial 16S rRNA gene and 5-
biotin-NAGAACCTGAAACCGTGTGC-3 (reverse primer) within the bacte-
rial 23S rRNA gene region were used. The PCR amplifications were performed
in 25-l volumes containing 1 U of Taq DNA polymerase (Qiagen Inc., Valencia,
CA), 1 Qiagen PCR buffer with 1.5 mM MgCl2, 200 M deoxynucleoside
triphosphate (dNTP) mix, 0.02% bovine serum albumin (BSA), and 10 pmol of
each primer. Four microliters of sample (extracted DNA) was added to the PCR
mixture, and PCR was performed in a PCT 100 thermal cycler (MJ Research,
Waltham, MA) as follows: 4 min of denaturation at 94°C, followed by 35 cycles
of 1 min of denaturation at 94°C, 1 min of annealing at 50°C, and 1 min of
extension at 72°C, with a final extension step of 10 min at 72°C.
Hybridization and scanning. Biotin-labeled PCR products were denatured for
5 min at 95°C and then chilled on ice for 5 min. Two microliters of single-
stranded biotin-labeled target DNA was mixed with 8 l of hybridization buffer
containing 1 SSC, 3 M formamide, salmon sperm DNA, BSA, dH2O, and
Cy5-streptavidin (Amersham Pharmacia Biotech, Piscataway, NJ). The oligonu-
cleotide chip was incubated for 30 min at 40°C. After hybridization, the slides
were washed for 4 min with 2 SSC and 0.2 SSC at room temperature and
dried by centrifugation to remove any remaining solution and reduce the back-
ground signal. The fluorescent image of the specific probes was obtained at 635
nm (Cy5), and that of the QC probes was obtained at 532 nm (TAMRA) by a
nonconfocal fluorescent scanner (GenePix 4000A; Axon Instruments, Foster
City, CA). The signal intensity (SI) of hybridization was analyzed using an
intelligent analysis program (CombiView software; GeneIn, Inc., Busan, South
Korea).
Sequencing of the bacterial 16S rRNA gene. After probe hybridization, the
result was compared with the blood culture identification result. If the two were
the same, the result was classified as category 1 (for definitions, see the next
paragraph), and no further study was performed. For all other specimens, the
PCR products were subjected to DNA sequencing. For 16S rRNA gene sequenc-
ing, the primers 16S-27F (5-AGAGTTTGATCMTGGCTCAG-3) and 16S-
518R (5-ATTACCGCGGCTGCTGG-3) were used to obtain approximately
491-bp nucleotides. The amplicons were purified using a QIAquick PCR kit
(Qiagen). The sequences of the PCR products were determined using an ABI
Prism BigDye Terminator Cycle Sequencing Ready Reaction Kit (Applied Bio-
systems, Foster City, CA) in the BaseStation-1 DNA fragment analyzer (MJ
Research).
Data comparison of blood culture, oligonucleotide chip, and 16S rRNA gene
sequencing. The oligonucleotide chip or sequencing data were compared with
the conventional identifications of blood culture isolates. The results were di-
vided into four categories. In category 1, the chip results were the same as the
blood culture results. These specimens were not subjected to DNA sequence
analysis. In category 2 the results for conventional identification and sequence
analysis were the same, but in the chip analysis there was an absence of
binding to the genus- or species-specific probes. In category 3 the results for
conventional identification and sequence analysis were the same, but in the
chip analysis there was nonspecific probe binding to either the genus- or the
species-specific probe. In category 4 the results for oligonucleotide chip
reaction patterns and sequence analysis were the same, but these differed
from the conventional identification.
RESULTS
For all 54 type strains used for specific probe binding, the
amplified products reacted with the universal probes, the cor-
responding Gram-positive or -negative probes, and the corre-
sponding genus- and/or species-specific probes with unique
hybridization patterns, as expected. For example, Streptococcus
pneumoniae was expected to hybridize with the probes
Uni_459, GP_01, GP_02, and Str and Str_pn, and the result
was as expected. Hybridization signal and intensity results of S.
pneumoniae and Escherichia coli are presented in Fig. 2 as
examples.
Among the 825 clinical specimens that were positive by
blood culture broth medium assay, 708 (85.8%) were identified
correctly by the oligonucleotide chip (correct answer group)
(Table 3, category 1,). Most (536, or 75.7%) were identified as
staphylococci, E. coli, or Klebsiella pneumoniae. In category 2,
there were 99 specimens that did not bind to any of the genus-
or species-specific probes, and all of the amplified products
proved to be the same species as detected by the blood cul-
tures. Thirty-seven (4.5%) did not bind to the specific probes
even though the corresponding probes were included on the
chip, suggesting low sensitivity of hybridization (low-sensitivity
group). Most of these also were identified as staphylococci, E.
coli, or K. pneumoniae and accounted for 6.3% of the total
number of species: staphylococci, 21/300 (7.0%); E. coli, 8/164
(4.9%); and K. pneumoniae, 5/72 (6.9%). The other 62 (7.5%)
belonged to a species for which genus- or species-specific
probes were not included in the current chip format, so no
specific probes were present for binding (no probe group).
Among them, Acinetobacter baumannii was the single most
frequent isolate (26/62). In category 3, 2 specimens for which
there were specific probes and 10 for which there were no
specific probes bound to the wrong probes, such that a total
1.5% of isolates yielded incorrect results (wrong answer
group). In category 4, six specimens (0.7%) showed different
results in the culture and chip identifications and were con-
firmed to have a DNA sequence of the amplified products
concordant with the chip reaction (unexplained answer group).
FIG. 1. Probe layout on oligonucleotide chip. For explanation of the probe names, see Table 1.
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Among 30 bacterial species for which specific probes were
included on the chip, 14 (Bacteroides ovatus, Bacteroides the-
taiotaomicron, Enterobacter agglomerans, Haemophilus ducreyi,
Listeria grayi, Listeria ivanovii, Listeria monocytogenes, Listeria
welshimeri, Pseudomonas stutzeri, Staphylococcus saprophyticus,
Serratia entomophila, Serratia grimesii, Streptococcus bovis, and
Streptococcus pyogenes) were not found among the 825 blood
culture isolates, indicating that probes for low-frequency iso-
lates were included.
DISCUSSION
Rapid and correct identification of microorganisms in blood
culture is critical for appropriate antibiotic use, eliminating
unnecessary antibiotic administration and facilitating early re-
covery of the patient. Therefore, many automated identifica-
tion and susceptibility testing systems are available (3, 11).
These can identify microorganisms and determine antibiotic
susceptibility in hours; however, they require pure colonies,
making overnight subculture of positive blood cultures inevi-
table. In a previous study, the oligonucleotide chip proved to
be the most effective way of detecting bacteria in clinical prac-
tice (15). Such chips offer the possibility of rapid and accurate
TABLE 2. Organisms tested
Organism and strain no. Probe types hybridizeda
Acinetobacter baumanii ATCC 19606 .............................U, N
Bacillus cereus KTCC 3711 ..............................................U, P
Bacteroides fragilis ATCC 25285......................................U, N, G, S
Bacteroides ovatus ATCC 8483........................................U, N, G, S
Bacteroides thetaiotaomicron ATCC 29741 ....................U, N, G, S
Bacteroides vulgatus ATCC 29327 ...................................U, N, G
Citrobacter freundii ATCC 33940 ....................................U, N
Enterobacter aerogenes ATCC 13048...............................U, N, G, S
Enterobacter agglomerans ATCC 27987..........................U, N, G, S
Enterobacter cloacae ATCC 13047 ..................................U, N, G, S
Enterobacter gergoviae ATCC 33426 ...............................U, N, G
Enterobacter sakazakii ATCC 29544 ...............................U, N, G
Enterococcus avium ATCC 14025 ...................................U, P, G, S
Enterococcus faecalis ATCC 19433 .................................U, P, G, S
Enterococcus faecium ATCC 8043 ..................................U, P, G, S
Enterococcus flavescens ATCC 49996 .............................U, P, G
Enterococcus solitarius ATCC 49428...............................U, P, G
Escherichia coli ATCC 10799 ..........................................U, N, S
Escherichia coli ATCC 33572 ..........................................U, N, S
Escherichia coli ATCC 39403 ..........................................U, N, S
Haemophilus ducreyi ATCC 33940..................................U, N, G, S
Haemophilus influenzae ATCC 19418.............................U, N, G, S
Klebsiella oxytoca ATCC 13182 .......................................U, N, G, S
Klebsiella planticola ATCC 15380 ...................................U, N, G
Klebsiella pneumoniae ATCC 15380 ...............................U, N, G, S
Listeria grayi ATCC 19120 ...............................................U, P, G, S
Listeria innocua ATCC 33090..........................................U, P, G
Listeria ivanovii subsp. ivanovii ATCC 19119 ................U, P, G, S
Listeria monocytogenes ATCC 19111 ..............................U, P, G, S
Listeria welshimeri ATCC 35897......................................U, P, G, S
Neisseria meningitidis ATCC 13077.................................U, N
Pseudomonas aeruginosa ATCC 10145...........................U, N, G, S
Pseudomonas reptilivora ATCC 14878 ............................U, N, G
Pseudomonas resinovorans ATCC 14235........................U, N, G
Pseudomonas stutzeri ATCC 17588 .................................U, N, G, S
Salmonella bongori ATCC 43975.....................................U, N
Serratia entomophila ATCC 43705 ..................................U, N, G, S
Serratia ficaria ATCC 33105 ............................................U, N, G
Serratia grimesii ATCC 14460 ..........................................U, N, G, S
Serratia marcescens ATCC 13880 ....................................U, N, G, S
Serratia odorifera ATCC 33077........................................U, N, G
Shigella boydii ATCC 8700...............................................U, N
Staphylococcus aureus ATCC 25923 ...............................U, P, G, S
Staphylococcus epidermidis ATCC 12228 .......................U, P, G, S
Staphylococcus homminis ATCC 27844..........................U, P, G
Staphylococcus saprophyticus ATCC 15305 ....................U, P, G, S
Staphylococcus warneri ATCC 35897 ..............................U, P, G
Streptococcus agalactiae ATCC 13813 ............................U, P, G, S
Streptococcus bovis ATCC 33317.....................................U, P, G, S
Streptococcus intermedius KCTC 3268............................U, P, G
Streptococcus mutans ATCC 25175.................................U, P, G
Streptococcus pneumoniae ATCC 33400.........................U, P, G, S
Streptococcus pyogenes ATCC 19615 ..............................U, P, G, S
Vibrio parahaemolyticus ATCC 17802.............................U, N
a Expected and tested results were the same. U, universal probe; N, Gram-
negative probe; P, Gram-positive probe; G, genus-specific probe; S, species-
specific probe.
TABLE 3. Classification of results
Probe group and organism Total no. ofspecimens
No. of specimens
by categorya
1 2 3 4
Bacteria targeted by specific probe
Bacteroides spp. 2 1 1
Escherichia coli 164 154 8 2
Enterobacter aerogenes 7 6 1
Enterobacter intermedius 1 1
Enterobacter cloacae 19 19
Enterococcus avium 1 1
Enterococcus faecalis 25 25
Enterococcus faecium 33 33
Enterococcus, other species 7 7
Haemophilus influenzae 1 1
Klebsiella oxytoca 3 3
Klebsiella ozaenae 1 1
Klebsiella pneumoniae 72 66 5 1
Pseudomonas aeruginosa 27 25 2
Serratia marcescens 4 4
Serratia, other species 1 1
Staphylococcus aureus 77 64 13
Staphylococcus epidermidis 136 136
Staphylococcus, other species 87 79 8
Streptococcus agalactiae 9 9
Streptococcus pneumoniae 31 31
Streptococcus, other species 45 43 2
Subtotal for group 753 708 37 2 6
Bacteria not targeted by specific probe
Acinetobacter baumannii 27 26 1
Acinetobacter junii 1 1
Aeromonas hydrophila 5 5
Aeromonas sobria 7 7
Alcaligenes xylosoxidans 1 1
Bacillus spp. 8 8
Burkhoderia cepacia 3 2 1
Citrobacter freundii 6 1 5
Corynebacterium xerosis 2 2
Flavobacterium meningosepticum 3 2 1
Gemella morbillorum 1 1
Morganella morganii 2 2
Pasteurella hemolytica 1 1
Stenotrophomonas maltophilia 5 5
Subtotal for group 72 62 10
Total both groups 825 708 99 12 6
a For a description of the categories, see Materials and Methods.
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diagnosis of a wide range of microorganisms through hybrid-
ization (16). In the current study, we evaluated oligonucleotide
chip-based identification of microorganisms directly from cul-
ture medium and demonstrated that 94% of species for which
probes were included were identified correctly in hours. This
chip contains most of the species frequently isolated from
blood such as coagulase-negative staphylococci and E. coli, as
judged by previous reports (9, 10). However, A. baumannii,
one of the frequent isolates, could not be identified because
specific probes were inadvertently omitted.
One problem implied by the results in category 2 is the
sensitivity of the oligonucleotide chip. Among 99 isolates in
that category that did not bind to any specific probes, 62 ac-
tually had no appropriate specific probes, so this problem may
be solved with additional probes. However, the remaining 37
isolates (5%) did not bind to their specific probes even though
such probes were present. We assume that the current version
of our oligonucleotide chip was not sensitive enough to detect
all isolates because these same strains were detected by se-
quencing. Another problem of the current chip was that it gave
us wrong information about 12 isolates (1.5% of the total).
One interesting finding was that the culture results were some-
times not consistent with the oligonucleotide chip and the
sequencing results. These results might be attributable to er-
roneous culture identification or to mixed blood cultures. Un-
fortunately, we could not determine the explanation by recul-
turing the medium because the stock specimens were used for
molecular work.
We chose the probes for the oligonucleotide chip empiri-
cally, so most of the frequent isolates from blood were in-
cluded. Accidentally, however, one important species (A. bau-
mannii) was not included, whereas probes for many rare
isolates were. For example, we did not find any references
documenting isolation of either H. ducreyi or L. welshimeri
from blood. The reason for their inclusion on the chip was that
at least one species of the same genus is an important blood
pathogen, and, therefore, many other species of the same ge-
nus were subjected to probe design and fitting. However, to
incorporate a rare pathogen’s probe consumes chip space and
is costly, so these probes will be eliminated in the next chip
design. Another concern in selecting probes was fungi, espe-
cially Candida spp. Fungal isolates are obtained in as many as
5% of all bacteremia and fungemia cases, and most of fungal
isolates are Candida spp. (1, 8). Furthermore, episodes of
fungemia have increased significantly over the years (1). Uni-
versal amplification of fungal isolates is different from that of
bacteria, so one more PCR amplification is necessary to detect
fungi isolated by the chip.
Recently, a small-scale study of DNA microarray-based
identification was reported for detecting bacteria and fungi in
blood cultures (20). The study targeted mainly the 23S rRNA
gene and the 16S–23S intergenic spacer region for bacteria and
18S rRNA gene for fungi. In target DNA amplification, two
separated tubes for bacteria and one tube for fungi were used.
It reported 93% sensitivity for 50 bacterial and seven fungal
species in 112 blood cultures. The authors did not clarify the
selection criteria for positive blood cultures. On the other
hand, the current study targeted only the 16S–23S intergenic
spacer region for bacteria, and a single tube was used for target
DNA amplification. And we included 825 consecutively sam-
pled positive blood cultures from five tertiary care hospitals so
that the general frequencies of and target probes for blood
pathogens could be revealed. Evaluation of our method by
consecutive samples demonstrated that single-tube amplifica-
FIG. 2. Hybridization pattern of clinical isolates with the oligonucleotide chip. (A) S. pneumoniae. (B) E. coli. Hybridization images (left) and
each probe’s relative signal intensity after hybridization (right) are shown. Solid and dotted boxes in the left images indicate corresponding
genus-specific and species-specific probes, respectively.
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tion is good enough to detect major bacterial pathogens. For
fungal amplification, however, another tube using universal
fungal primers would be necessary. Another concern about the
microarray-based detection methods, including the current
study, is their direct application to blood. “Most bacteremias in
adults have a low number of CFU per milliliter (ml) of blood”
(6). Therefore, direct application of a PCR-based method to a
small amount of blood is not easy. In some cases, however,
bacteria can be seen in a Wright-stained blood smear. Also,
high levels of bacteremia (more than 1,000 CFU/ml of blood)
are detected in some infants (6). Very recently, direct applica-
tions of molecular detection methods have been reported (4,
17, 18). Direct application of an oligonucleotide chip for de-
tecting blood pathogens, if possible, will greatly improve the
detection of fastidious or slow-growing microorganisms such as
Haemophilus, Actinobacillus, Cardiobacterium, Eikenella, and
Kingella (HACEK group). Therefore, efforts to extend the
applicability of our method directly to blood specimens should
be encouraged.
In conclusion, the oligonucleotide chip was highly specific
and sensitive in detecting the causative agents of bacteremia
directly from positive blood cultures. However, the current
format failed to detect some isolates despite inclusion of spe-
cific probes, so improvement of the probe design is required.
Also, the application of more probes for frequent isolates and
extension to fungi will help in diagnosing bloodstream infec-
tion rapidly and correctly.
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